Shanghai Wibson Biotechnology: difference between revisions

Diff·revision 15 → 16·04:21, 9 Mar 2025

Difference between revision 15 and revision 16 of Shanghai Wibson Biotechnology. 6 lines changed; the page grew by 897 bytes.

Revision 15 — 22:09, 3 Mar 2025 COA_Colwyn (talk) tag ^{[citation needed]} 4,104 bytes +182	Revision 16 — 04:21, 9 Mar 2025 VerifyFirstVida (talk) rm citation to a supplier's own page 5,001 bytes +897
25	The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.	25	The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
26		26
+		27	== Operations and documentation practice ==
+		28	Purchaser reports describe conventional practice: lyophilised material in crimped glass vials, batch certificate enclosed, cold pack for the temperature-sensitive lines.{{r\|reports}} Certificates in submitted material have typically reported a purity figure and an appearance line without a water content, so the reported purity cannot be converted into a net mass.{{r\|usp1503}}
+		29
27	== References ==	30	== References ==
28	{{reflist}}	31	{{reflist}}
29	<ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref>	32	<ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref>
30	<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>	33	<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>
+		34	<ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref>
31	<ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref>	35	<ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref>
+		36	<ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref>
32	<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>	37	<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>
33		38
⋮		⋮
36	[[Category:Suppliers in China]]	41	[[Category:Suppliers in China]]
37	[[Category:Certificates of analysis]]	42	[[Category:Certificates of analysis]]
+		43	[[Category:Testing methodology]]
38		44